Clinical Research Organization
Hello,
we are a prominent nyc-based expert network and an authorized zintro partner
our client has an immediate need to conduct phone consults with multiple experts knowledgeable about contract / clinical research organization (cro) industry. More specifically, they are hoping to better understand the overall market growth, trends & outlook, as well as key segments.
Here's more information on the type of people they are looking to speak with:
• a cross-section of pharma and biotech players of different sizes
o expert must have ownership of development pipeline
o have expertise related to key large/growing tas (therapeutic areas) and regions – initial hypothesis is focused on oncology, infectious diseases/vaccines, immunology
o we would probably like to speak to mostly us players, some european and a couple in asia
• sponsor members who own (or influence) outsourcing decisions (e.G., operations, clinical research)
• cro members responsible for strategy/planning and pricing decisions
• potentially across other segments of the value chain
thanks,
tj
+19 Other ResponsesBusiness Development For Contract/clinical Research Organisation
Looking for an expert to help in business development strategies and tactics for a niche cro (contract/clinical research organisation), specifically as it relates to exploiting scientific expertise and connecting to scientific decision makers in pharma and biotech
+18 Other ResponsesPre-clinical Cro Market – Comparative Medicine
We are a global market research firm and are seeking experts who can assist us in understanding the ‘global pre-clinical cro market – comparative medicine’
key questions:
1. Kindly brief us on the key market trends related to comparative medicine (xenograft studies, lab animals and animal feed etc.) and toxicology studies
2. Which are the key innovations/advanced technologies offered by different vendors in the space of pre-clinical studies?
A. What is the impact of digitization on the management of animal breeds?
B. How the market is expected to evolve through 2025?
3. Which are the best practices adopted by leading pharmaceutical companies to build a category strategy in the space of comparative medicine and toxicology studies?
4. Kindly provide information around the current market scenario of pre-clinical studies including animal testing, in-vivo testing, pharmacokinetics and toxicology etc.
5. Which are the leading vendors in the global pre-clinical services market?
A. Which is the preferred vendor segment for ease of animal sourcing?
B. Kindly name top 10 vendors. What % market share do they occupy from the global pre-clinical services market? Which are their key capabilities?
6. Which are the different types of pricing models in the industry?
A. Rate card vs module based pricing
b. Most adopted pricing model currently
7. Information around animal supply chain (key focus on monkey supply) for pre-clinical studies.
A. Are there any chances of animal supply shortage in the future?
B. Which are the most preferred regions for animal sourcing and why?
I. Is asia getting more preferred for animal (monkey) supply?
C. Information on the animal supply market dynamics and how the global market place is evolving through 2025?
8. Case studies explaining best practices adopted by leading pharmaceutical companies to build a category strategy-
a. How leading pharma companies are managing the category - comparative medicine and toxicology studies (in terms of supplier identification, and contracting)?
B. Most adopted engagement models
c. Most adopted pricing models
d. How do the pharma companies streamline the process of managing the category and stakeholders?
E. Cost reduction strategies
we are looking for a phone consult for a period of 1 hour to discuss all points mentioned above.
+24 Other ResponsesContract Research Org (cro) Price Benchmarking
We are a global market research firm, currently looking for experts who can assist us in price benchmarking of various types of tests conducted by cros (contract research organizations)
the types of tests in which we are interested are given below:
clinical routine labs (e.G., chemistries, lipids, hormone levels, viral serologies/pcr, vitamins, heavy metals)
genomics whole-genome sequencing
genomics rna sequencing
genomics metagenomics
genomics methylation assays
immunology cytof
immunology flow cytometry
immunology tcr/bcr sequencing
proteomics targeted affinity-based proteomics
proteomics untargeted mass spectrometry
proteomics targeted (mrm) mass spectrometry
metabolomics untargeted mass spectrometry
metabolomics targeted (mrm) mass spectrometry
we are looking for an expert to discuss the points mentioned above. Ideal candidates should have deep knowledge of prices offered by different cros
kindly drop in a note with your cv/relevant experience in the pharmaceutical industry, if you are interested to proceed.
Best regards,
thomas
+40 Other ResponsesClinical Research Organization (cro)
**please respond to the following request with a proposal if:
1) you currently, or within the last year, work at a pharmaceutical or biotech firm.
2) you are familiar with phase 1 clinical trials.
Familiarity with and understanding of how biopharma and pharmaceutical companies decide which cros to use for early stage phase 1 clinical research. Will be able to speak to growth trends related to spending on r&d in industry and spending on cro services. To the extent possible, will be able to speak to how this may differ for innovator versus generic drugs. Will be able to speak to the reputations of different cro service providers for early stage phase 1.
1) how has your spending on cro early stage services trended in the past few years? What is your outlook for demand for cro services? Why? To the extent you can speak to this, how has this differed for generic vs. Innovator drugs?
2) what is the decision process for determining which early stage phase 1 cro to use?
3) what factors are considered when determining which early stage phase 1 cro to use?
4) what are the early stage phase 1 cros that come to mind? Which cros have you considered? How do cro reputations differ across the different stages of clinical research (early vs. Late)? For different clinical services?
5) what are the trends for early stage phase 1 cro services moving overseas?
Areas of expertise:
seeking experts with knowledge of clinical trials, phase 1-4; clinical trials; early clinical research; cro; early stage clinical research; cros; clinical research organization; clinical research
+7 Other ResponsesVice President, Biometrics
Join a team that works on groundbreaking compounds and profoundly impacts patients’ lives! our client is a distinct, full-service contract research organization with offices in california, massachusetts, and quebec. Due to their growth and investment they have recently relocated our headquarters to southborough, ma. They are serious about scientific integrity and have a dynamic company culture, including a focus on work-life balance.
Value proposition for you:
* flexible work schedule.
* proven potential for professional growth.
* a community of brilliant minds at your disposal.
* the stability of working for a robust, financially sound cro that is growing at a sustainable pace.
* exposure to more than 20 therapeutic areas, including cutting edge therapies such as immuno-oncology, biosimilars, gene therapy, and new molecular entities.
As the vice president, biometrics you will…
* be a critical part of the global core leadership team by being responsible for the guidance and strategic direction of the global biostatistic and data management teams.
* advance the overall success and future growth of our client by having executive contact with current clients, providing key client oversight and strategic project contribution, and contributing to new business development.
* develop and implement department strategies to increase productivity and quality, while decreasing cycle times and costs. Oversee the data management and statistical aspects of client projects and project teams.
* participate in presentations of capabilities and research proposals to prospective clients. Represent data management and biostatistics in marketing efforts by developing project bid proposals, participating at bid defense meetings, or performing client presentations.
* provide oversight of the hiring and management of personnel. Ensure that adequate training occurs and that performance evaluations are completed.
* and much more!
education:
degree in statistics, biostatistics, math, or a related field. Phd or master’s degree preferred.
Experience:
* at least 15 years of relevant work experience and at least 5 years of supervisory experience.
* experience in a leadership position within biostatistics or data management for a cro.
* have previously contributed to the overall strategic direction of a company or business unit.
* thorough knowledge of ich gcp guidelines and other applicable regulatory rules and guidelines and of medical terminology, clinical trials, and clinical research.
* working knowledge of the relationship and regulatory obligation of the cro industry with pharmaceutical/biotech companies.
+27 Other ResponsesPharma Qualitative Study
We are seeking highly specialized experts with experience in the life sciences industry - must meet below specifications
location: usa - san fransisco bay area, los angeles, philadelphia, new york, boston.
Industry: pharmaceuticals, contract development and manufacturing organizations (cdmos)/clinical research organizations (cros), and life science market research.
Testing availability: late june - early july
study 2: qualitative study - one on one either telephonic or in-person interviews
**respondent profile**:
cost estimates for both tdi (telephonic interviews) and idi (in person interviews) with 8 respondents, 2 each from clinical trial supply managers/coordinators/directors, procurement contacts / outsourcing managers / directors, clinical / pre-clinical teams, senior executives (pharma/biotech/cro)
**expert's job titles**:
1) clinical trial supply managers / coordinators / directors
2) procurement contacts / outsourcing managers / directors
3) clinical / pre-clinical teams
4) senior executives
**experts must have a clear understanding of the following topics (doesn't have to be an expert at each level, but at least one, also a basic understanding of others)**:
a. Api services & chemical development – all stages of drug development for small molecules, potent and cytotoxic compounds, and peptides
b. Pharmaceutical development – development cycle of clinical candidate into an optimum formulation and clinical stages manufacturing
c. Analytical services – analytical services supporting drug substance (api) and drug product development including cmc regulatory filings
d. Clinical trial supply – clinical supplies, packaging, distribution and delivery of clinical protocols, supply chain management.
E. Clinical technologies - solutions for patient enrollment, screening randomization, drug assessment etc.
F. Commercial services – api supply, manufacturing, testing and packaging to end-user distribution.
+18 Other ResponsesFte In Pharmaceutical Industry
I would like to know pharmaceutical industry average number of ftes/resources in-house who conduct 15-20 clinical studies annually, outsources clinical trials to cros(contract research organizations) and has an internal team who can validate the data generated by cros.
Thank you
+35 Other ResponsesCro Outsourcing In Clinical Trial
We are a market research company looking for the following information pertaining to cros on behalf of our client:
unique cro outsourcing trends in the clinical trial (cro) industry where cros have been innovative in how they offer services to pharmaceutical companies; real life examples between cros and pharmaceutical companies
preferred or approved supplier for major pharmaceutical companies
how other pharmaceutical companies validate cro rates without going out to bid?
Supplier analysis and market analysis
+24 Other ResponsesContract Research Organizations
We would like to speak with an expert who can help us in gathering the information on cros direct cost data for specific cro services. We would like to cover cost per site and cost per patient estimates based on the following parameters:
geographical focus: north america and western eu
services required:
• site feasibility
• site identification
• site qualification
• site initiation
• essential document collection
• site management
• site monitoring
• project management
+15 Other ResponsesContract Research Organization Market
We are an established, us-based firm researching the cro (contract research organization) market, specifically providers focused on data management and biostatistical services. We are interested in speaking with business development professionals from the cro industry as well as c-level executives from the biopharmaceutical industry.
Note: we seeking professionals from boutique to mid-size organizations (e.G. Generic pharmaceuticals, boutique cros and biopharmaceutical companies with less than $100m in revenue) rather than those with "big pharma" or top-tier cro experience.
Please include your relevant experience in this space, and where you fit within the above specifications.
+33 Other ResponsesPharma Research Interviewees
We are seeking highest specialized experts with experience in the life sciences industry - must meet below specifications
location: usa - san fransisco bay area, los angeles, philadelphia, new york, boston.
Industry: pharmaceuticals, contract development and manufacturing organizations (cdmos)/clinical research organizations (cros), and life science market research.
Testing availability: late june - early july
study 1: qualitative study - focus group interviews with 3 groups (6-8 respondents per group)
**respondent profile**:
group 1: 6-8 pharmaceutical executives from top 20 biotech companies who are influencers, contributors or decision makers on outsourcing services to contract development and manufacturing organizations (cdmos)/clinical research organizations (cros).
Group 2: 6-8 pharmaceutical executives from top 10 clinical research organizations (cros) companies who are influencers, contributors or decision makers on outsourcing services to contract development and manufacturing organizations (cdmos)/contract research organizations.
Group 3: 6-8 pharmaceutical executives from small / mid-sized pharmaceutical companies who are influencers, contributors or decision makers on outsourcing services to contract development and manufacturing organizations (cdmos)/contract research organizations.
**expert must have** a clear understanding of the following topics (doesn't have to be an expert at each level, but at least one, also a basic understanding of others):
a. Api services & chemical development – all stages of drug development for small molecules, potent and cytotoxic compounds, and peptides
b. Pharmaceutical development – development cycle of clinical candidate into an optimum formulation and clinical stages manufacturing
c. Analytical services – analytical services supporting drug substance (api) and drug product development including cmc regulatory filings
d. Clinical trial supply – clinical supplies, packaging, distribution and delivery of clinical protocols, supply chain management.
E. Clinical technologies - solutions for patient enrollment, screening randomization, drug assessment etc.
F. Commercial services – api supply, manufacturing, testing and packaging to end-user distribution.
+15 Other Responses
